NKNebojša Koledin
Nebojša Koledin
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nebojša Koledin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Riccardo Caponetto
Department of Engineering, University of Messina, Messina, Italy
2 shared publications - Iqra Shafeeq Mughal
Dipartimento di Ingegneria, Elettrica, Elettronica e Informatica—DIEEI, University of Catania, Viale Andrea Doria, 6, 95125 Catania, Italy
1 shared publication - Luca Patanè
University of Messina
1 shared publication - Martin Steinberger
Institute of Automation and Control, Graz University of Technology, Graz, Austria
1 shared publication - Roberto Garrappa
Department of Mathematics, University of Bari, Bari, Italy
1 shared publication - Stefan Koch
Institute of Automation and Control Graz University of Technology Graz Austria
1 shared publication
Latest Publications
- 20 February 2026
- Published by Springer Nature in Nonlinear Dynamics
- Vol. 114 (4) , 237
Deriving analytical voltage response in fractional order battery modeling
- 20 February 2026
- Published by Springer Nature in Nonlinear Dynamics
- Vol. 114 (4) , 237
Deriving analytical voltage response in fractional order battery modeling
- Open Access
- 23 November 2025
- Published by MDPI AG in Electronics
- Vol. 14 (23) , 4585
Model Predictive Control Using the Improved Hovorka Model for the Regulation of Blood Glucose Levels in Type 1 Diabetes
Type 1 diabetes is an autoimmune disease that occurs when the immune system unintentionally attacks and damages cells in the pancreas, reducing the organ’s ability to produce insulin. An artificial pancreas is a technology that uses a pump to inject the appropriate amount of insulin subcutaneously after analysing information collected by sensors, including continuous blood glucose monitoring. Over the past thirty years, several methods for controlling an artificial pancreas have been investigated in clinical and simulation environments. The improved Hovorka model, a comprehensive nonlinear model that explains the effects of insulin on transport, disposal and endogenous synthesis in both accessible and inaccessible compartments for blood glucose control by insulin administration, is used for this research. The presented model has the characteristics of a switching nonlinear system. The work proposes to analyse different nonlinear control strategies for blood glucose regulation and shows the effectiveness of the linear model predictive control strategy compared to other nonlinear controllers used in the literature.- 23 November 2025
- Published by MDPI AG in Electronics
- Vol. 14 (23) , 4585
Open AccessModel Predictive Control Using the Improved Hovorka Model for the Regulation of Blood Glucose Levels in Type 1 Diabetes
Type 1 diabetes is an autoimmune disease that occurs when the immune system unintentionally attacks and damages cells in the pancreas, reducing the organ’s ability to produce insulin. An artificial pancreas is a technology that uses a pump to inject the appropriate amount of insulin subcutaneously after analysing information collected by sensors, including continuous blood glucose monitoring. Over the past thirty years, several methods for controlling an artificial pancreas have been investigated in clinical and simulation environments. The improved Hovorka model, a comprehensive nonlinear model that explains the effects of insulin on transport, disposal and endogenous synthesis in both accessible and inaccessible compartments for blood glucose control by insulin administration, is used for this research. The presented model has the characteristics of a switching nonlinear system. The work proposes to analyse different nonlinear control strategies for blood glucose regulation and shows the effectiveness of the linear model predictive control strategy compared to other nonlinear controllers used in the literature.